Key clinical point: Magnetic sphincter augmentation was superior to twice-daily proton pump inhibitor therapy for controlling regurgitation.
Major finding: Regurgitation was controlled in 96% of magnetic sphincter augmentation patients versus 19% of patients receiving proton pump inhibitor.
Study details: The data come from a 1-year randomized trial of 152 adults with moderate to severe regurgitation.
Disclosures: Dr. Bell and several coauthors disclosed honoraria from Ethicon for teaching services. The study was supported in part by Ethicon.
Bell R et al. Clin Gastro Hepatol. 2019. doi: 10.1016/j.cgh.2019.08.056